An 8q24 gene desert variant associated with prostate cancer risk confers differential in vivo activity to a MYC enhancer.
An 8q24 gene desert variant associated with prostate cancer risk confers differential in vivo activity to a MYC enhancer. Genome Res. 2010 Sep; 20(9):1191-7.